25 Feb 2019 – Edison Investment Research publish Research Note on Destiny Pharma entitled “Prevention is commercially cost effective”
News
Monday February 25, 2019
25 Feb 2019 – Edison Investment Research publish Research Note on Destiny Pharma e...
Edison Investment Research Limited today published a Research Note on Destiny Pharma by Analyst Andy Smith entitled “Prevention is commercially cost effective”. The research can be found here and the […]